載入...
Randomized, Placebo-Controlled, Single-Ascending-Dose Study of BMS-791325, a Hepatitis C Virus (HCV) NS5B Polymerase Inhibitor, in HCV Genotype 1 Infection
BMS-791325 is a nonnucleoside inhibitor of hepatitis C virus (HCV) NS5B polymerase with low-nanomolar potency against genotypes 1a (50% effective concentration [EC(50)], 3 nM) and 1b (EC(50), 7 nM) in vitro. BMS-791325 safety, pharmacokinetics, and antiviral activity were evaluated in a double-blind...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4068419/ https://ncbi.nlm.nih.gov/pubmed/24733462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02579-13 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|